GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » Asset Turnover

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Asset Turnover : 0.16 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Carl Zeiss Meditec AG Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Carl Zeiss Meditec AG's Revenue for the three months ended in Dec. 2023 was $518 Mil. Carl Zeiss Meditec AG's Total Assets for the quarter that ended in Dec. 2023 was $3,237 Mil. Therefore, Carl Zeiss Meditec AG's Asset Turnover for the quarter that ended in Dec. 2023 was 0.16.

Asset Turnover is linked to ROE % through Du Pont Formula. Carl Zeiss Meditec AG's annualized ROE % for the quarter that ended in Dec. 2023 was 7.08%. It is also linked to ROA % through Du Pont Formula. Carl Zeiss Meditec AG's annualized ROA % for the quarter that ended in Dec. 2023 was 5.04%.


Carl Zeiss Meditec AG Asset Turnover Historical Data

The historical data trend for Carl Zeiss Meditec AG's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Asset Turnover Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.77 0.68 0.75 0.67 0.74

Carl Zeiss Meditec AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.19 0.20 0.19 0.16

Competitive Comparison of Carl Zeiss Meditec AG's Asset Turnover

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Asset Turnover falls into.



Carl Zeiss Meditec AG Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Carl Zeiss Meditec AG's Asset Turnover for the fiscal year that ended in Sep. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Sep. 2023 )/( (Total Assets (A: Sep. 2022 )+Total Assets (A: Sep. 2023 ))/ count )
=2229.776/( (2794.868+3236.845)/ 2 )
=2229.776/3015.8565
=0.74

Carl Zeiss Meditec AG's Asset Turnover for the quarter that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=517.993/( (3236.845+0)/ 1 )
=517.993/3236.845
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Carl Zeiss Meditec AG  (OTCPK:CZMWF) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Carl Zeiss Meditec AG's annulized ROE % for the quarter that ended in Dec. 2023 is

ROE %**(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=163.14/2304.646
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(163.14 / 2071.972)*(2071.972 / 3236.845)*(3236.845/ 2304.646)
=Net Margin %*Asset Turnover*Equity Multiplier
=7.87 %*0.6401*1.4045
=ROA %*Equity Multiplier
=5.04 %*1.4045
=7.08 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Carl Zeiss Meditec AG's annulized ROA % for the quarter that ended in Dec. 2023 is

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=163.14/3236.845
=(Net Income / Revenue)*(Revenue / Total Assets)
=(163.14 / 2071.972)*(2071.972 / 3236.845)
=Net Margin %*Asset Turnover
=7.87 %*0.6401
=5.04 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Carl Zeiss Meditec AG Asset Turnover Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.